Published in Transplantation on April 15, 2008
The role of polyomaviruses in human disease. Virology (2008) 2.41
Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol (2010) 1.31
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol (2010) 1.04
Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection. MBio (2011) 1.02
Comparative Evaluation of Three Nucleic Acid-Based Assays for BK Virus Quantification. J Clin Microbiol (2015) 0.81
[Infections in organ transplantations]. Pathologe (2011) 0.78
Clinical reasoning: agitation and psychosis in a patient after renal transplantation. Neurology (2012) 0.78
Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement. J Clin Microbiol (2015) 0.78
Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia. Transpl Infect Dis (2015) 0.76
Possible antiviral effect of ciprofloxacin treatment on polyomavirus BK replication and analysis of non-coding control region sequences. Virol J (2013) 0.75
BK Virus Associated Late Onset Haemorrhagic Cystitis After Allogeneic Peripheral Blood Stem Cell Transplant. Indian J Hematol Blood Transfus (2011) 0.75
Reining in polyoma virus associated nephropathy: design and characterization of a template mimicking BK viral coat protein cellular binding. Biochemistry (2012) 0.75
Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrol Dial Transplant (2009) 1.74
Outcome of the living kidney donor. Nephrol Dial Transplant (2012) 1.57
Estimating glomerular filtration rate in Asian subjects: where do we stand? Kidney Int (2011) 1.47
Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients? Transplantation (2007) 1.41
Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol (2010) 1.40
Measurement uncertainty of creatinine in low values: Another good reason not to use the MDRD formula with low creatinine values. Clin Biochem (2006) 1.38
Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant (2008) 1.37
High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol (2009) 1.29
Changing concepts in the management of liver hydatid disease. J Gastrointest Surg (2005) 1.28
Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant (2008) 1.18
Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg (2010) 1.18
How to tackle the avalanche of chronic kidney disease in sub-Saharan Africa: the situation in the Democratic Republic of Congo as an example. Nephrol Dial Transplant (2006) 1.13
Spurious systolic hypertension in youth: what does it really mean in clinical practice? J Hypertens (2006) 1.08
[Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital]. Nephrol Ther (2010) 1.07
Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrol Dial Transplant (2007) 1.06
Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit (2004) 1.05
MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrol (2010) 1.03
Normal reference values for glomerular filtration rate: what do we really know? Nephrol Dial Transplant (2012) 1.01
Indexing of renal function parameters by body surface area: intelligence or folly? Nephron Clin Pract (2011) 0.98
Impact of radiofrequency assisted hepatectomy for reduction of transfusion requirements. Am J Surg (2007) 0.96
Tolvaptan in autosomal dominant polycystic kidney disease. N Engl J Med (2013) 0.96
Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care (2004) 0.96
Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clin Chim Acta (2008) 0.95
Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis. Pancreas (2004) 0.95
Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine. BMC Nephrol (2014) 0.94
Anorexia nervosa and the kidney. Am J Kidney Dis (2012) 0.92
Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant (2013) 0.92
Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrol (2013) 0.92
Optimal blood pressure level and best measurement procedure in hemodialysis patients. Vasc Health Risk Manag (2005) 0.92
Gallbladder villous adenoma in a patient with acromegaly: a case report. World J Gastroenterol (2007) 0.89
Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron Clin Pract (2014) 0.89
Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations? Clin J Am Soc Nephrol (2011) 0.89
Modalities of testing Helicobacter pylori in patients with nonmalignant bile duct diseases. World J Gastroenterol (2002) 0.88
Urinary NGAL measurement: biological variation and ratio to creatinine. Clin Chim Acta (2010) 0.87
Large-pore membrane hemofiltration increases cytokine clearance and improves right ventricular-vascular coupling during endotoxic shock in pigs. Artif Organs (2006) 0.87
Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study. Clin Drug Investig (2007) 0.87
Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol (2014) 0.86
Performance of iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment. Clin Chim Acta (2008) 0.85
Estimation of the stability of parathyroid hormone when stored at -80 degrees C for a long period. Clin J Am Soc Nephrol (2009) 0.85
Liver resection with a new multiprobe bipolar radiofrequency device. Arch Surg (2008) 0.85
Results of kidney transplantation from controlled donors after cardio-circulatory death: a single center experience. Transpl Int (2011) 0.84
Modification of Diet in Renal Disease versus Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in obese patients. Nephrol Dial Transplant (2013) 0.84
Tumor-induced osteomalacia: The tumor may stay hidden! Clin Biochem (2011) 0.83
Analytical validation of the new version of the Liaison N-Tact PTH assay. Clin Chem Lab Med (2007) 0.83
Estimated glomerular filtration rate. Ann Intern Med (2007) 0.83
Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scand J Clin Lab Invest (2009) 0.82
Effects of n-3 Fatty Acids Supplementation on Plasma Phospholipids Fatty Acid Composition in Patients with Obstructive Jaundice- a Pilot Study. J Clin Biochem Nutr (2009) 0.82
Kidney donation after circulatory death in a country with a high number of brain dead donors: 10-year experience in Belgium. Transpl Int (2012) 0.81
Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa. Nephron Clin Pract (2008) 0.81
Trimethoprim, creatinine and creatinine-based equations. Nephron Clin Pract (2011) 0.80
A new technique for spleen preservation with radiofrequency. Surgery (2006) 0.80
Mature erythrocyte indices: new markers of iron availability. Haematologica (2005) 0.80
Evaluation of different bone markers in hemodialyzed patients. Clin Chim Acta (2006) 0.79
Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study. BMC Nephrol (2012) 0.79
Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? Clin Chim Acta (2012) 0.78
[Creatinine: past and present]. Ann Biol Clin (Paris) (2010) 0.78
Creatinine calibration in NHANES: is a revised MDRD study formula needed? Am J Kidney Dis (2008) 0.78
New data on the intraindividual variation of cystatin C. Nephron Clin Pract (2008) 0.78
Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage? The laboratory's point of view. Clin Chem Lab Med (2010) 0.78
Feasibility of applying data mining techniques for predicting technical difficulties during laparoscopic cholecystectomy based on routine patient work-up in a small community hospital. Hepatogastroenterology (2013) 0.78
Cystatin C-based equations: don't repeat the same errors with analytical considerations. Nephrol Dial Transplant (2007) 0.77
Creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients. Clin Transplant (2006) 0.76
Vitamin D treatment in chronic kidney disease: what we really need to know. Arch Intern Med (2008) 0.75
The RIFLE criteria: are the foundations robust? Crit Care Med (2007) 0.75
Radiofrequency-assisted liver resection does not induce severe liver damage. World J Surg (2008) 0.75
Paricalcitol for reduction of albuminuria in diabetes. Lancet (2011) 0.75
The new Mayo Clinic equation for estimating glomerular filtration rate. Ann Intern Med (2005) 0.75
C-reactive protein and dialysis access. Kidney Int (2009) 0.75
Letter by Delanaye et al regarding article, "Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction". Circulation (2007) 0.75
Chronic kidney disease in Taiwan. Lancet (2008) 0.75
Cystatin C, renal function, and cardiovascular risk. Ann Intern Med (2008) 0.75
Analytical variation in plasma renin activity: implications for the screening of primary aldosteronism. Clin Chem (2007) 0.75
Clamp-crushing vs. radiofrequency-assisted liver resection:changes in liver function tests. Hepatogastroenterology (2012) 0.75
Acetylcysteine and enzymatic creatinine: beware of laboratory artefact! Intensive Care Med (2007) 0.75
[The role of mesenchymal stromal cells in solid organ transplantation]. Rev Med Suisse (2014) 0.75
Comparison of Liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients. Clin Chem Lab Med (2005) 0.75
The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients Is Not Influenced by Renal Function. Clin Nucl Med (2016) 0.75
[Measurement of inulin: development]. Ann Biol Clin (Paris) (2011) 0.75
[EVOLVE: between disappointment and optimism]. Nephrol Ther (2013) 0.75
[Indexing glomerular filtration rate for body surface area: myth and reality]. Nephrol Ther (2009) 0.75
Back pain and renal failure. Lancet (2004) 0.75
Impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein. Clin Chem Lab Med (2015) 0.75
Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter? Nephrol Dial Transplant (2012) 0.75
Impact of erythropoietic activity on red cell parameters in chronic renal failure patients. Haematologica (2004) 0.75
Relationship between papillary fibrosis and patency of the accessory pancreatic duct. Ann Anat (2005) 0.75
[Fibrillary nonamyloid glomerulonephritis: a rare etiology of nephrotic syndrome]. Nephrol Ther (2011) 0.75